Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00CEE
|
|||
| Former ID |
DIB015252
|
|||
| Drug Name |
Tetraxim
|
|||
| Synonyms |
Repevax; Td5, Aventis Pasteur MSD; TdacpIPV booster vaccine, Aventis Pasteur; DTaP + IPV, Aventis Pasteur MSD; Diphtheria, tetanus, pertussis, polio vaccine (1); Diphtheria, tetanus, pertussis, polio vaccine (1), Aventis Pasteur MSD
Click to Show/Hide
|
|||
| Indication | Bordetella pertussis infection [ICD-11: 1C12.0; ICD-10: A37.0] | Approved | [1], [2] | |
| Company |
Sanofi Pasteur MSD
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT02145624) A Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.